title: The effects of antisense interleukin-4 gene transferred by recombinant adeno-associated virus vector on the airway remodeling in allergic rats.
abstract: BACKGROUND
  Th2-derived cytokines, including interleukin-4 (IL-4), are considered to play an important role in the development of airway remodeling of asthma.
  
  
  OBJECTIVE
  Our previous study has demonstrated that a recombinant adeno-associated virus containing antisense against IL-4 gene (rAAV-asIL4) vector could significantly suppress the expression of IL-4 protein and airway inflammation in the rat models of allergic asthma. In this study, we applied the rAAV-asIL4 vector to allergic rats to investigate the effects of anti-IL4 therapy on airway remodeling in allergic asthma.
  
  
  METHODS
  rAAV-asIL4 was used to infect the ovalbumin (OVA)-sensitized and challenged rats by tail-vein injection. IL-4 protein in bronchoalveolar lavage fluid (BALF) was detected by enzyme-linked immunosorbent assay. The number of eosinophils in BALF was counted. Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2-positive cells in the peribronchial space were detected by immunohistochemical staining, and collagen deposition beneath the basement membrane was detected by Sirius red stain. The lung tissues were collected for histologic analysis of total bronchial wall area (W(At)) and airway smooth muscle area (W(Am)).
  
  
  RESULTS
  rAAV-asIL4 significantly decreased IL-4 protein in BALF of OVA-sensitized and challenged rats. The number of eosinophils in BALF, the TGF-beta1 and TGF-beta2-positive cells in the peribronchial space were also suppressed. Moreover, the rAAV-asIL4 treatment inhibited the area of Sirius red staining in airways and the increase in W(At) and W(Am).
  
  
  CONCLUSIONS
  These results suggest that rAAV-asIL4 may attenuate the airway remodeling process relevant to the inhibition of airway inflammation. This study provides elementary evidence for the potential utility of rAAV-asIL4 as an approach to gene therapy for asthmatic airway remodeling.
authors.affiliation: Department of Respiratory Medicine, Tongji Hospital, Key Laboratory of Pulmonary Diseases of the Ministry of Health of China, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China.
authors.forename: Yong
authors.initials: Y
authors.lastname: Cao
authors.forename: Daxiong
authors.initials: D
authors.lastname: Zeng
authors.forename: Qingfeng
authors.initials: Q
authors.lastname: Song
authors.forename: Chao
authors.initials: C
authors.lastname: Cao
authors.forename: Min
authors.initials: M
authors.lastname: Xie
authors.forename: Xiansheng
authors.initials: X
authors.lastname: Liu
authors.forename: Shengdao
authors.initials: S
authors.lastname: Xiong
authors.forename: Yongjian
authors.initials: Y
authors.lastname: Xu
authors.forename: Weining
authors.initials: W
authors.lastname: Xiong
mesh_terms: D056151:Airway Remodeling; D000818:Animals; D001249:Asthma / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry / Q000166:cytology; D016373:DNA, Antisense / Q000235:genetics*; D000229:Dependovirus; D004797:Enzyme-Linked Immunosorbent Assay; D004804:Eosinophils / Q000378:metabolism; D005822:Genetic Vectors; D006967:Hypersensitivity / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D015847:Interleukin-4 / Q000096:biosynthesis* / Q000235:genetics; D008168:Lung / Q000473:pathology; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D053773:Transforming Growth Factor beta1 / Q000378:metabolism; D053781:Transforming Growth Factor beta2 / Q000378:metabolism
chemical_list: D016373:DNA, Antisense; D053773:Transforming Growth Factor beta1; D053781:Transforming Growth Factor beta2; D015847:Interleukin-4